WO2013043041A3 - Methods and compositions for diagnosing familial hypercholesterolemia - Google Patents
Methods and compositions for diagnosing familial hypercholesterolemia Download PDFInfo
- Publication number
- WO2013043041A3 WO2013043041A3 PCT/MY2012/000253 MY2012000253W WO2013043041A3 WO 2013043041 A3 WO2013043041 A3 WO 2013043041A3 MY 2012000253 W MY2012000253 W MY 2012000253W WO 2013043041 A3 WO2013043041 A3 WO 2013043041A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- familial hypercholesterolemia
- diagnosing familial
- diagnosing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A method for diagnosing Familial Hypercholesterolemia (FH) and/or predisposition to FH in an individual of Asian descent, the method comprising detecting the presence of at least one single nucleotide polymorphism (SNP) in a sample of the individual.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2011004478 | 2011-09-21 | ||
MYPI2011004478 | 2011-09-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013043041A2 WO2013043041A2 (en) | 2013-03-28 |
WO2013043041A3 true WO2013043041A3 (en) | 2013-08-01 |
Family
ID=47915056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/MY2012/000253 WO2013043041A2 (en) | 2011-09-21 | 2012-09-21 | Methods and compositions for diagnosing familial hypercholesterolemia |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013043041A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201308313D0 (en) * | 2013-05-09 | 2013-06-19 | Medical Res Council | Assay Method |
CN104263723B (en) * | 2014-09-15 | 2017-06-06 | 南京医科大学 | A kind of low frequency related to primary lung cancer auxiliary diagnosis penetrance genetic marker high and its application |
CN110592185A (en) * | 2018-12-25 | 2019-12-20 | 首都医科大学附属北京安贞医院 | Method for designing hypercholesteremia virulence gene screening probe and gene chip thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040019005A1 (en) * | 2001-10-01 | 2004-01-29 | Jeffrey Van Ness | Methods for parallel measurement of genetic variations |
US20040248177A1 (en) * | 2003-04-25 | 2004-12-09 | Marianne Abi Fadel | Human hypercholesterolemia causal gene and use thereof |
-
2012
- 2012-09-21 WO PCT/MY2012/000253 patent/WO2013043041A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040019005A1 (en) * | 2001-10-01 | 2004-01-29 | Jeffrey Van Ness | Methods for parallel measurement of genetic variations |
US20040248177A1 (en) * | 2003-04-25 | 2004-12-09 | Marianne Abi Fadel | Human hypercholesterolemia causal gene and use thereof |
Non-Patent Citations (3)
Title |
---|
ALEX LIVY ET AL.: "Familial hypercholesterolemia in Asia: a review", JOURNAL OMICS RESEARCH, vol. 1, no. 1, 27 October 2011 (2011-10-27), pages 22 - 31, XP055081782 * |
AL-KHATEEB A. ET AL.: "Analysis of sequence variations in low-density lipoprotein receptor gene among Malaysian patients with familial hypercholesterolemia", BMC MEDICAL GENETICS, vol. 12, no. 40, 19 March 2011 (2011-03-19), pages 1 - 11, XP021096524 * |
LIVY ALEX ET AL.: "Differences in allele frequencies of autosomal dominant hypercholesterolemia SNPs in the Malaysian population", JOURNAL OF HUMAN GENETICS, vol. 57, 26 April 2012 (2012-04-26), pages 358 - 362 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013043041A2 (en) | 2013-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL256307B (en) | Methods and systems for detecting an analyte or classifying a sample | |
EP3090058A4 (en) | Systems, compositions and methods for detecting and analyzing micro-rna profiles from a biological sample | |
MX2020004617A (en) | Cardiovascular risk event prediction and uses thereof. | |
WO2012012725A3 (en) | Methods of detecting diseases or conditions using phagocytic cells | |
WO2013070756A3 (en) | System and method for processing samples | |
GB2481950B (en) | Surface microstructure measurement method, surface microstructure measurement data analysis method and surface microstructure measurement system. | |
WO2011120006A8 (en) | Detection system for droplet-based assays | |
WO2012047618A3 (en) | Mesothelioma biomarkers and uses thereof | |
WO2014058760A3 (en) | Preloaded test substrates for testing lal-reactive substances, methods of use, and methods of making | |
WO2012021795A3 (en) | Pancreatic cancer biomarkers and uses thereof | |
WO2012019200A3 (en) | Assay systems for determination of source contribution in a sample | |
EA201590027A1 (en) | DETECTION METHODS OF DISEASES OR CONDITIONS | |
EP2753914A4 (en) | Automated sample handling instrumentation, systems, processes, and methods | |
EP2649447A4 (en) | Sample analysis system | |
EP2356469A4 (en) | Open platform automated sample processing system | |
WO2009015863A3 (en) | Methods of detecting methylated dna at a specific locus | |
EP2280642A4 (en) | Automated task execution for an analyte monitoring system | |
WO2012170206A3 (en) | Color-producing diagnostic systems, reagents and methods | |
WO2010075360A3 (en) | Methods for detection of sepsis | |
WO2012174378A3 (en) | Methods and materials for assessing allelic imbalance | |
WO2014005125A3 (en) | Fluorescent compounds and uses thereof | |
WO2013028807A3 (en) | Renal cell carcinoma biomarkers and uses thereof | |
WO2013090857A8 (en) | Identification of two novel biomarkers for niemann-pick disease type c | |
EP2638178A4 (en) | Compositions, methods, and kits for detecting and identifying mycobacteria | |
WO2013028544A3 (en) | Compositions and methods for detecting and discriminating between yeast or mold |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12833352 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12833352 Country of ref document: EP Kind code of ref document: A2 |